Ilyang Pharmaceutical Co., Ltd. (007570)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
8,500. 00
-30
-0.3517%
₩
233.92B Market Cap
- P/E Ratio
150% Div Yield
45,975 Volume
- Eps
₩ 8,530
Previous Close Want to track 007570 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
007570 closed today lower at ₩8,500, a decrease of -0.3517% from yesterday's close, completing a monthly decrease of -4.6016% or -₩410. Over the past 12 months, 007570 stock lost -34.8659%.
007570 pays dividends to its shareholders, with the most recent payment made on Apr 27, 2026. The next estimated payment will be in In 10 months on Apr 27, 2027 for a total of ₩150.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Ilyang Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Mar 04, 2011.
The company's stock is traded on one exchange.
Ilyang Pharmaceutical Co., Ltd. (007570) FAQ
What is the stock price today?
The current price is ₩8,500.00.
On which exchange is it traded?
Ilyang Pharmaceutical Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 007570.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 150%.
What is its market cap?
As of today, the market cap is 233.92B.
Has Ilyang Pharmaceutical Co., Ltd. ever had a stock split?
Ilyang Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Mar 04, 2011.
Ilyang Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Dong-Yeon Kim CEO | KRX SM Exchange | KR7007570005 ISIN |
| KR Country | 666 Employees | 27 Dec 2024 Last Dividend | 4 Mar 2011 Last Split | - IPO Date |
Overview
Ilyang Pharmaceutical Co.,Ltd is a prominent entity in the pharmaceutical industry, primarily operating within South Korea. The inception of the company dates back to 1946, initially known as Il-Yang Pharm. Ind. Co. before it underwent a name change to Ilyang Pharmaceutical Co., Ltd. in May 1991. The company’s headquarters are situated in Yongin, South Korea. Throughout its rich history, Ilyang Pharmaceutical Co.,Ltd has expanded both its product range and market reach, including exports of its products to international markets.
Products and Services
The company’s portfolio is expansive, covering a wide spectrum of medical and health-related products and services:
- Medicines: Ilyang Pharmaceutical provides a diverse range of medications catering to various health needs, including anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology treatments.
- Health and Wellness Products: Beyond pharmaceuticals, the company ventures into health drinks, daily food, supplements, health food, cosmetics, and beverages, reflecting its holistic approach to health and wellbeing.
- Antibiotics and Antifungal Drugs: A critical segment of Ilyang Pharmaceutical’s offerings includes antibiotics and antifungal drugs, combating infections and diseases caused by bacteria and fungi.
- Anti-inflammatory Analgesic Drugs: These drugs are designed to alleviate pain and reduce inflammation, serving as essential components in pain management and treatment of inflammatory conditions.
- Insecticides and Vaccines: The company also provides insecticides and vaccines, contributing to public health efforts by controlling insect-borne diseases and preventing viral and bacterial infections.
- Pharmaceutical Raw Materials Products: Catering to the industry's backend, Ilyang Pharmaceutical produces a broad range of pharmaceutical raw materials, including various forms of aluminum hydroxide, magnesium hydroxide, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, and synthetic aluminum silicate, among others. These raw materials are crucial for the production of numerous pharmaceutical formulations.
Contact Information
Address: 110, Hagal-ro, Yongin, South Korea, 17096
Phone: 82 3 1281 7851
Website: https://home.ilyang.co.kr
